Wuhan YZY Biopharma’s HK$176 Million Initial Public Offering

Cooley, Jingtian & Gongcheng and King & Wood Mallesons advised YZY Biopharma, while Sidley and Merits & Tree acted as legal counsel for the sole sponsor…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Pietro Martinoia

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here